Pfizer CEO, MD, chairman, board of directors and AGM
NSE: PFIZERBSE: 500680Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹3,688.90.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹16,525 Cr327th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 28 Jul 2026
- 22.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 12 May 2026
- 3.9
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 2.08%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 28 Jul 2026
- 17.5%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 28 Jul 2026
- 21.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 12 May 2026
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 19,15150.9% delivered
Pfizer board of directors
At the end of the quarter to Jun 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- ChairpersonPradip Panalal Shah
- Managing director and CEOMeenakshi Nevatia
- Company Secretary and Compliance OfficerPrajeet Nair
7 directors3 independent3 executive1 non-executive
- Pradip Panalal Shah · ChairpersonNon-executive · joined Nov 2024 · reappointed Nov 2024 · 18 months as independent · 4 listed boards · 2 as independent · 7 committee seats, 2 as chair
- Meena GaneshIndependent · joined Mar 2019 · reappointed Mar 2024 · 87 months as independent · 5 listed boards · 5 as independent · 7 committee seats, 2 as chair
- Lakshmanan KrishnakumarIndependent · joined Jul 2024 · reappointed Jul 2024 · 23 months as independent · 1 listed board · 1 as independent · 4 committee seats, 3 as chair
- Sonia SinghIndependent · joined Jul 2024 · reappointed Jul 2024 · 23 months as independent · 5 listed boards · 5 as independent · 5 committee seats, 2 as chair
- Meenakshi Nevatia · Managing director and CEOExecutive · joined Apr 2023 · reappointed Apr 2023 · 0 months as independent · 2 listed boards · 1 as independent · 2 committee seats
- Amit AgarwalExecutive · joined Feb 2024 · reappointed Feb 2024 · 0 months as independent · 1 listed board
- P RenganExecutive · joined Oct 2023 · reappointed Oct 2023 · 0 months as independent · 1 listed board · 1 committee seat
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
2 directors who left
- Sunil Lalbhai, left 13 Feb 2025: Tenure Completion
- Uday Khanna, left 9 Nov 2024: Tenure Completion
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 12 May 20267 of 7 present3 independent · 91 days in between
- 9 Feb 20267 of 7 present3 independent
Audit Committee
Chair Lakshmanan Krishnakumar
Pradip Panalal Shah, Meena Ganesh
- 12 May 20263 of 3 present2 independent · 91 days in between
- 9 Feb 20263 of 3 present2 independent
Nomination and remuneration committee
Chair Meena Ganesh
Pradip Panalal Shah, Lakshmanan Krishnakumar, Sonia Singh
- 12 May 20264 of 4 present3 independent · 91 days in between
- 9 Feb 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Meena Ganesh
Lakshmanan Krishnakumar, Meenakshi Nevatia, P Rengan
No meeting listed in the filing.
Risk Management Committee
Chair Sonia Singh
Meena Ganesh, Meenakshi Nevatia, Amit Agarwal
No meeting listed in the filing.
Corporate Social Responsibility Committee
Chair Pradip Panalal Shah
Sonia Singh, Meenakshi Nevatia, Amit Agarwal, P Rengan
No meeting listed in the filing.
Board Administrative and Share Transfer Committee
Chair Meenakshi Nevatia
Amit Agarwal, P Rengan
No meeting listed in the filing.
Independent Directors' Meeting
- 12 May 20263 of 3 present3 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- B S R & Co. LLPPeer-review certificate valid to Jul 2028
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Pfizer AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Pfizer dividend history
Annual general meeting, 28 Jul 2026
1,05,890 shareholders on the register on 17 Jul 2026; present: 7 promoters and 39 others; votes counted by Nrupang B. Dholakia / Dholakia & Associates LLP.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026, including the Reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.20%
Turnout: all 81.96% · promoters 100.00% · institutions 91.92% · other public 0.56%
- To declare a final dividend of Rs. 75/- per equity share of Rs. 10/- (750%) for the financial year ended March 31, 2026.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.18%
Turnout: all 81.96% · promoters 100.00% · institutions 91.92% · other public 0.56%
ORDINARY - To consider appointment of a Director in place of Mr. P. Rengan (DIN: 10362899), who retires by rotation pursuant to section 152(6) of Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
Ordinary99.77% for0.23% againstAgainst: promoters 0.00% · institutions 1.04% · other public 0.24%
Turnout: all 81.95% · promoters 100.00% · institutions 91.92% · other public 0.46%
- Ratification of remuneration payable to M/s. Kishore Bhatia & Associates, Cost Accountants for the financial year ending March 31, 2027.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.32%
Turnout: all 81.95% · promoters 100.00% · institutions 91.92% · other public 0.46%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 21 Jul 2025, 5 resolutions
1,08,832 shareholders on the register on 9 Jul 2025; present: 7 promoters and 49 others; votes counted by Nrupang B. Dholakia / Dholakia & Associates LLP.The company's voting result (opens in a new tab)
- To receive, consider and adopt the audited financial statement of the Company for the financial year ended March 31, 2025, including the reports of the Board of Directors and Auditors thereon.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 83.83% · promoters 100.00% · institutions 91.20% · other public 12.98%
- To declare a dividend of Rs. 165/- (1650%) per equity share for the financial year ended March 31, 2025.Ordinary99.99% for0.01% against
Against: promoters 0.00% · institutions 0.07% · other public 0.00%
Turnout: all 83.85% · promoters 100.00% · institutions 91.28% · other public 12.98%
- Re-appointment of Mr. Amit Agarwal (DIN: 10465938) as a Director, liable to retire by rotation.Ordinary99.84% for0.16% against
Against: promoters 0.00% · institutions 0.75% · other public 0.07%
Turnout: all 83.85% · promoters 100.00% · institutions 91.26% · other public 12.98%
- To consider and ratify the remuneration payable to Messers Kishore Bhatia and Associates Cost Accountants for the financial year ending March 31, 2026Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.02%
Turnout: all 83.85% · promoters 100.00% · institutions 91.26% · other public 12.98%
- To consider appointment of Messers Parikh and Associates as the Secretarial Auditors of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 83.85% · promoters 100.00% · institutions 91.26% · other public 12.98%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 28 Aug 2024, 8 resolutions
Present: 6 promoters and 57 others.The company's voting result (opens in a new tab)
- To receive, consider and adopt the audited financial statement of the Company for the financial year ended March 31, 2024, including the reports of the Board of Directors and Auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.89%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.85%
- To declare a dividend of Rs.35/- (350%) per equity share for the financial year ended March 31, 2024Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.88%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.85%
- Appointment of Mr. P. Rengan (DIN: 10362899) as a Director liable to retire by rotationOrdinary99.85% for0.15% against
Against: promoters 0.00% · institutions 0.67% · other public 0.96%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.84%
- To consider appointment of Mr. Pradip Shah (DIN: 00066242) as a Non-Executive Non-Independent Director of the Company with effect from November 10, 2024Special98.02% for1.98% against
Against: promoters 0.00% · institutions 9.02% · other public 1.18%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.84%
- To consider appointment of Mr. Lakshmanan Krishnakumar (DIN: 00423616) as an Independent Director for a term of 5 (five) consecutive years with effect from July 29, 2024Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.87%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.84%
- To consider appointment of Ms. Sonia Singh (DIN: 07108778) as an Independent Director for a term of 5 (five) consecutive years with effect from July 29, 2024Special100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 2.43%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.84%
- To consider and ratify the remuneration payable to Messrs. Kishore Bhatia & Associates, Cost Accountants for the financial year ended March 31, 2024Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.23%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.85%
- To consider and ratify the remuneration payable to M/s. Kishore Bhatia & Associates, Cost Accountants for the financial year ending March 31, 2025Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 1.23%
Turnout: all 82.11% · promoters 100.00% · institutions 92.42% · other public 0.84%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 30 Mar 2024, 2 resolutions
The company's voting result (opens in a new tab)
- Appointment of Mr. Amit Agarwal (DIN: 10465938) as a Whole-Time Director & Chief Financial Officer of the Company for a period of 5 years with effect from February 26, 2024Ordinary99.13% for0.87% against
Against: promoters 0.00% · institutions 4.07% · other public 1.65%
Turnout: all 81.44% · promoters 100.00% · institutions 93.69% · other public 0.74%
- Re-appointment of Ms. Meena Ganesh (DIN: 00528252) as an Independent Director for Second Term of 5 years with effect from March 8, 2024Special94.35% for5.65% against
Against: promoters 0.00% · institutions 26.42% · other public 2.87%
Turnout: all 81.44% · promoters 100.00% · institutions 93.69% · other public 0.74%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 6 Jan 2024, 1 resolution
The company's voting result (opens in a new tab)
- APPOINTMENT OF MR. P. RENGAN (DIN: 10362899) AS A WHOLE-TIME DIRECTOR OF THE COMPANY FOR A PERIOD OF 5 YEARS WITH EFFECT FROM OCTOBER 28, 2023Ordinary99.11% for0.89% against
Against: promoters 0.00% · institutions 4.27% · other public 2.53%
Turnout: all 80.68% · promoters 100.00% · institutions 92.21% · other public 0.45%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 18 Aug 2023, 5 resolutions
Present: 7 promoters and 60 others.The company's voting result (opens in a new tab)
- To receive, consider and adopt the audited financial statement of the Company fornthe financial year ended March 31, 2023, including the reports of the Board of Directors andnAuditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.21%
Turnout: all 80.59% · promoters 100.00% · institutions 93.72% · other public 0.42%
- To declare a final dividend of Rs.40 (400%) per equity share for the financial year ended March 31, 2023Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.45%
Turnout: all 80.59% · promoters 100.00% · institutions 93.72% · other public 0.42%
- Appointment of Mr. Samir Kazi (DIN: 07184083) as a Director liable to retire by rotationOrdinary98.85% for1.15% against
Against: promoters 0.00% · institutions 5.56% · other public 0.89%
Turnout: all 80.59% · promoters 100.00% · institutions 93.72% · other public 0.42%
- To consider revision in the limit of commission payable to Non-Executive DirectorsOrdinary99.46% for0.54% against
Against: promoters 0.00% · institutions 2.59% · other public 3.13%
Turnout: all 80.59% · promoters 100.00% · institutions 93.72% · other public 0.42%
- To consider and ratify the remuneration payable to Messrs. RA & Co., Cost Accountants for the financial year ending March 31, 2024OrdinaryPromoters have an interest in it100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.85%
Turnout: all 80.58% · promoters 100.00% · institutions 93.72% · other public 0.42%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Postal ballot, 27 May 2023, 1 resolution
The company's voting result (opens in a new tab)
- APPOINTMENT OF MS. MEENAKSHI NEVATIA (DIN: 08235844) AS A DIRECTOR AND MANAGING DIRECTOR OF THE COMPANY WITH EFFECT FROM APRIL 3, 2023Ordinary99.72% for0.28% against
Against: promoters 0.00% · institutions 1.36% · other public 0.15%
Turnout: all 82.83% · promoters 100.00% · institutions 94.42% · other public 11.97%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Annual general meeting, 26 Aug 2022, 5 resolutions
Present: 7 promoters and 55 others.The company's voting result (opens in a new tab)
- Adoption of audited financial statement for financial year ended March 31,2022Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.46% · promoters 100.00% · institutions 90.68% · other public 28.78%
- Declaration of Dividend of Rs. 35 per equity shares for financial year ended March 31, 2022Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 80.47% · promoters 100.00% · institutions 90.68% · other public 28.81%
- Appointment of Mr. Milind Patil, DIN: 02546815 as a Director liable to retire by rotationOrdinary99.45% for0.55% against
Against: promoters 0.00% · institutions 4.92% · other public 0.01%
Turnout: all 80.47% · promoters 100.00% · institutions 90.68% · other public 28.78%
- To consider appointment of B S R & Co. LLP as the Statutory Auditor of the CompanyOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.01%
Turnout: all 80.46% · promoters 100.00% · institutions 90.68% · other public 28.78%
- To consider and ratify the remunration payble to Messrs. RA & Co. Cost Accountants for financial year ending March 31, 2023Ordinary99.33% for0.67% against
Against: promoters 0.00% · institutions 5.92% · other public 0.01%
Turnout: all 80.46% · promoters 100.00% · institutions 90.68% · other public 28.78%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
How mutual funds voted
Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it
Mutual fund votes, meeting of 28 Jul 2026, 11 fund houses so far (houses' deadline to file 15 Oct 2026)
- To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2026, including the Reports of the Board of Directors and Auditors thereon.11 for0 against
- To declare a final dividend of Rs. 75/- per equity share of Rs. 10/- (750%) for the financial year ended March 31, 2026.11 for0 against
ORDINARY - To consider appointment of a Director in place of Mr. P. Rengan (DIN: 10362899), who retires by rotation pursuant to section 152(6) of Companies Act, 2013 and being eligible, offers himself for re-appointment.MoreLess
11 for0 against- Ratification of remuneration payable to M/s. Kishore Bhatia & Associates, Cost Accountants for the financial year ending March 31, 2027.11 for0 against
Mutual fund votes, meeting of 21 Jul 2025, 21 fund houses
- To receive, consider and adopt the audited financial statement of the Company for the financial year ended March 31, 2025, including the reports of the Board of Directors and Auditors thereon.21 for0 against
- To declare a dividend of Rs. 165/- (1650%) per equity share for the financial year ended March 31, 2025.21 for0 against
- Re-appointment of Mr. Amit Agarwal (DIN: 10465938) as a Director, liable to retire by rotation.21 for0 against
- To consider and ratify the remuneration payable to Messers Kishore Bhatia and Associates Cost Accountants for the financial year ending March 31, 202621 for0 against
- To consider appointment of Messers Parikh and Associates as the Secretarial Auditors of the Company21 for0 against
6 earlier meetings
Mutual fund votes, meeting of 28 Aug 2024, 11 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- To receive, consider and adopt the audited financial statement of the Company for the financial year ended March 31, 2024, including the reports of the Board of Directors and Auditors thereon11 for0 against
- To declare a dividend of Rs.35/- (350%) per equity share for the financial year ended March 31, 202411 for0 against
- Appointment of Mr. P. Rengan (DIN: 10362899) as a Director liable to retire by rotation11 for0 against
- To consider appointment of Mr. Pradip Shah (DIN: 00066242) as a Non-Executive Non-Independent Director of the Company with effect from November 10, 2024
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundCompliant with Law. Governance Concern: No cooling off period served before appointment as NED-NID post completion of two terms as an ID.
10 for1 against - To consider appointment of Mr. Lakshmanan Krishnakumar (DIN: 00423616) as an Independent Director for a term of 5 (five) consecutive years with effect from July 29, 2024
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundNo concern on the merit of proposed appointees. Non-Compliant with SEBI LODR & Companies Act, 2013: Terms and Conditions of appointment of proposed IDs not disclosed on the website of the Company and Assurance statement of independence by Board not disclosed.
10 for1 against - To consider appointment of Ms. Sonia Singh (DIN: 07108778) as an Independent Director for a term of 5 (five) consecutive years with effect from July 29, 2024
Against Motilal Oswal Mutual Fund
- Motilal Oswal Mutual FundNo concern on the merit of proposed appointees. Non-Compliant with SEBI LODR & Companies Act, 2013: Terms and Conditions of appointment of proposed IDs not disclosed on the website of the Company and Assurance statement of independence by Board not disclosed.
10 for1 against - To consider and ratify the remuneration payable to Messrs. Kishore Bhatia & Associates, Cost Accountants for the financial year ended March 31, 20248 for0 against
- To consider and ratify the remuneration payable to M/s. Kishore Bhatia & Associates, Cost Accountants for the financial year ending March 31, 20258 for0 against
4 proposals not matched to one resolution
- 7) Ratify remuneration of Rs. 1,470,000 to Kishore Bhatia & Associates as cost auditors for FY24.1 for0 against
- 8) Ratify remuneration of Rs. 1,470,000 to Kishore Bhatia & Associates as cost auditors for FY25.1 for0 against
- Ratify remuneration of Rs. 1,470,000 to Kishore Bhatia & Associates as cost auditors for FY242 for0 against
- Ratify remuneration of Rs. 1,470,000 to Kishore Bhatia & Associates as cost auditors for FY252 for0 against
Mutual fund votes, meeting of 30 Mar 2024, 16 fund houses
- Appointment of Mr. Amit Agarwal (DIN: 10465938) as a Whole-Time Director & Chief Financial Officer of the Company for a period of 5 years with effect from February 26, 2024
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST this resolution is warranted in view of the following concerns: • The board does not have at least one-half independent director (post reclassification) and Amit Agarwal is a non-independent director nominee.
15 for1 against - Re-appointment of Ms. Meena Ganesh (DIN: 00528252) as an Independent Director for Second Term of 5 years with effect from March 8, 2024
Against Groww Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund, Nippon India Mutual Fund, Zerodha Mutual Fund
- Groww Mutual Fund, Motilal Oswal Mutual FundNo concern on the merit of proposed appointee. Non-Compliance: Re-appointment is not in accordance with law, no prior shareholders’ approval obtained for re-appointment as an ID.
- Kotak Mahindra Mutual FundNo concern has been identified with the profile, time commitments, attendance and independence of Ms. Meena Ganesh. However, the power to re-appoint Independent Directors rests with the shareholders, and the Board cannot re-appoint her directly. The term of Ms. Meena Ganesh has already ended on 7th March 2024. Therefore, in order to be eligible for re-appointment, the shareholders approval should have been obtained prior to her term coming to an end. Hence, such approval should have been obtained on or before 7th March, 2024. The resolution is non-compliant by the law and doesn t adhere to the provisions of Companies Act, 2013. Hence voting against.
- Nippon India Mutual FundShareholder's approval not obtained on time for appointment of director
- Zerodha Mutual FundThe re-appointment of the concerned person as an ID for the second term is not in accordance with the law.
11 for5 against
Mutual fund votes, meeting of 6 Jan 2024, 16 fund houses
- APPOINTMENT OF MR. P. RENGAN (DIN: 10362899) AS A WHOLE-TIME DIRECTOR OF THE COMPANY FOR A PERIOD OF 5 YEARS WITH EFFECT FROM OCTOBER 28, 2023
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST this resolution is warranted in view of the following concerns: The board is not at least one-half independent (post our reclassification) and P. Rengan is a non-independent director nominee.
15 for1 against
Mutual fund votes, meeting of 18 Aug 2023, 13 fund houses
Each resolution counts the houses whose vote was matched to it; the rest are listed last.
- To receive, consider and adopt the audited financial statement of the Company fornthe financial year ended March 31, 2023, including the reports of the Board of Directors andnAuditors thereon12 for0 against
- To declare a final dividend of Rs.40 (400%) per equity share for the financial year ended March 31, 202313 for0 against
- Appointment of Mr. Samir Kazi (DIN: 07184083) as a Director liable to retire by rotation
Against HSBC Mutual Fund
- HSBC Mutual FundA vote AGAINST the re-election of Samir Salauddin Kazi is warranted because: The board is chaired by a non-executive director and the board is not at least one-third independent and Samir Salauddin Kazi is a non-independent director nominee..
12 for1 against - To consider revision in the limit of commission payable to Non-Executive Directors
Against HSBC Mutual Fund
- HSBC Mutual FundNon-executive directors participate in performance-based incentive schemes.
12 for1 against - To consider and ratify the remuneration payable to Messrs. RA & Co., Cost Accountants for the financial year ending March 31, 202413 for0 against
1 proposal not matched to one resolution
- Accept Financial Statements and Statutory Reports1 for0 against
Mutual fund votes, meeting of 27 May 2023, 14 fund houses
- APPOINTMENT OF MS. MEENAKSHI NEVATIA (DIN: 08235844) AS A DIRECTOR AND MANAGING DIRECTOR OF THE COMPANY WITH EFFECT FROM APRIL 3, 202314 for0 against
Mutual fund votes, meeting of 26 Aug 2022, 10 fund houses
- Adoption of audited financial statement for financial year ended March 31,202210 for0 against
- Declaration of Dividend of Rs. 35 per equity shares for financial year ended March 31, 202210 for0 against
- Appointment of Mr. Milind Patil, DIN: 02546815 as a Director liable to retire by rotation10 for0 against
- To consider appointment of B S R & Co. LLP as the Statutory Auditor of the Company10 for0 against
- To consider and ratify the remunration payble to Messrs. RA & Co. Cost Accountants for financial year ending March 31, 202310 for0 against
Each fund house counted once, from its own disclosure; the reasons are its own words.
Tax disputes
Reported in the filing for the quarter to Jun 2026.
- Tax disputeDeputy Commissioner of Income TaxSince 31 Jan 2018The matter is pending before Hon'ble High Court of Bombay.At the filing before: The dispute against the tax demand of Rs.98.45 crores (including interest) on disallowance of depreciation and certain expenses for FY 2014-15 was pending before Hon'ble High Court of Bombay.
- Tax disputeDeputy Commissioner of Income TaxSince 2 Feb 2017The matter is pending before Hon'ble High Court of Bombay.At the filing before: The dispute against the tax demand of Rs.80.05 crores (including interest) on disallowance of depreciation and certain expenses for FY 2013-14 was pending before Hon'ble High Court of Bombay.
- Tax disputeDeputy Commissioner of Income TaxSince 18 Jan 2019The matter is pending before Hon'ble High Court of Bombay.At the filing before: The dispute against the tax demand of Rs.61.31 crores (including interest) on disallowance of depreciation and certain expenses for FY 2015-16 was pending before Hon'ble High Court of Bombay.
- Tax disputeAssistant Commissioner of Income TaxSince 24 Jan 2020
Both the appeals before the Commissioner of Income Tax are pending . ITAT has allowed the Company to withdraw appeal with a liberty to approach again in case of unfavourable order from lower appellate authority and hon'ble Bombay High Court has granted a stay till appeal before ITAT is decided.MoreLess
At the filing before: (1) The dispute against tax demand of Rs.44.25 crores raised due to disallowance of depreciation and certain expenses in assessment under section 143(3) for FY 2016-17 was pending before Commissioner of Income Tax (Appeals). (2) Writ filed by the Company is disposed off by Hon'ble High Court against order under section 143(3) giving effect to the order of the Principal Commissioner under section 263 with incremental tax effect of Rs.12.69 crores having been passed beyond the statutory timelines by asking us to approach lower authorities. And accordingly company has filed an appeal with CIT(A) against such order with a limited ground of validity of such order. (3)Further, re-characterization of short term capital gains proposed by Principal Commissioner of Income Tax in proceedings under section 263 was challenged before the Income Tax Appellate Tribunal has now been withdrawn by company as per directives of High Court, with a liberty to approach Tribunal again in case of adverse order from lower authorities.MoreLess
- Tax disputeAssessment Unit, Income Tax DepartmentSince 25 Oct 2023The matter is pending before the Commissioner of Income Tax (Appeals).At the filing before: The dispute against the tax demand of Rs.32.40 crores (including interest) on disallowance of depreciation and certain expenses for FY 2019-20 was pending before Commissioner of Income Tax (Appeals).
- Tax disputeAssessment Unit, Income Tax DepartmentSince 23 Apr 2026The matter is pending before Commissioner of Income Tax (Appeals).
At the filing before: The dispute against the tax demand of Rs.85.74 crores (including interest) on account of alleged under reporting of income and certain other disallowances for FY 2022-23. The Company has filed an appeal before Commissioner of Income Tax (Appeals) against the said order.MoreLess
- Tax disputeNational Pharmaceutical Pricing AuthoritySince 10 Dec 2018The matter is pending before Hon'ble High Court of Bombay.
At the filing before: Writ petition filed with the Hon'ble High Court of Bombay against the demand of Rs. 48.46 crores raised by NPPA alleging price increase in excess of permissible limit for the period April 2015 to August 2017.MoreLess
- Tax disputeNational Pharmaceutical Pricing AuthoritySince 28 Jan 2008The matter is pending before Hon'ble High Court of Bombay.At the filing before: Writ petition is filed with the Hon'ble High Court of Bombay against the alleged demand of Rs. 45.09 crore raised by NPPA in 2007 in respect of 6 bulk drugs & formulations thereof.
In the company's own words, from its latest governance filing.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- Yes
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- Yes
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.